Skip to search formSkip to main contentSkip to account menu

Marqibo

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Vincristine sulfate liposomevincristine liposome
vincristine liposome Injection [Marqibo]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Phase II study of hyper-CMAD with Liposomal Vincristine (Marqibo) for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia
2016
2016
Phase II study of vincristine sulfate liposomes injection in patients with metastatic uveal melanoma
9067 Background: Preclinical and clinical studies showed that liposomal encapsulation of vincristine sulfate (VCR) results in… 
2015
2015
Liposomal Vincristine (Marqibo) Combined with Hyper-Cmad As Frontline Therapy for Patients with Acute Lymphoblastic Leukemia: A Result of a Phase II Clinical Trial
Background: Liposomal vincristine has been approved as salvage chemotherapy for patients with relapsed/refractory acute… 
2011
2011
Vincristine sulfate liposomes injection (VSLI) "bridging" to potentially curative hematopoietic stem cell transplantation (HSCT) in adults with Philadelphia chromosome negative (Ph-) acute…
6527 Background: In a phase II, multi-national study (RALLY Trial; NCT00495079 ), 65 adults (median age 32 yrs, range 19 to 83… 
2010
2010
Phase II study of marqibo in adult patients with refractory or relapsed philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).
6507 Background: Management of adult ALL patients who relapse is challenging due to highly drug resistant disease and frequent… 
2009
2009
Phase II study of vincristine sulfate liposomes injection in patients with metastatic uveal melanoma.
9067 Background: Preclinical and clinical studies showed that liposomal encapsulation of vincristine sulfate (VCR) results in… 
2007
2007
Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) Concentrates Vincristine in Tumor Tissue and Lymphoid Malignancy Oriented Tissues in Tumor-Bearing Mice.
Background: Vincristine sulfate (VCR) is a cell-cycle specific, lipophilic, anti-cancer drug that inhibits cell division by… 
Review
2007
Review
2007
Safety and Efficacy of Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) in for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL).
Introduction: Vincristine sulfate (VCR) is a lipophilic, cell-cycle specific, antineoplastic agent that inhibits cell division by… 
2007
2007
Marqibo (Vincristine Sulfate Liposomes Injection (OPTISOME™) Demonstrates Activity in Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma.
Introduction: New and more effective agents are needed to improve treatment outcomes for patients with relapsed and refractory… 
2005
2005
ODAC Votes Unanimously Not to Recommend Approval for Marqibo, a Liposomal Vincristine, for Aggressive NHL
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)